Fourth Amendment to Shareholder Rights Agreement, dated as of 22, 2017, between the Company and Computershare Trust Company, N.A., as Rights Agent

EX-4.1 2 amendmenttorightsplansept2.htm EXHIBIT 4.1 Exhibit

FOURTH AMENDMENT 
TO 
SHAREHOLDER RIGHTS AGREEMENT 
This FOURTH AMENDMENT TO SHAREHOLDER RIGHTS AGREEMENT is made and entered into as of September 22, 2017 (this “Amendment”), between CTI BioPharma Corp., a Washington corporation, and Computershare Trust Company, N.A., a federally chartered trust company (the “Rights Agent”). The capitalized terms used and not otherwise defined herein have the respective meanings given to them in that certain Shareholder Rights Agreement, between the Company and the Rights Agent, dated as of December 28, 2009, as amended by that certain First Amendment to Shareholder Rights Agreement, between the Company and the Rights Agent, dated August 31, 2012, as further amended by that certain Second Amendment to Shareholder Rights Agreement, between the Company and the Rights Agent, dated December 6, 2012, and as further amended by that certain Third Amendment to Shareholder Rights Agreement, between the Company and the Rights Agent, dated December 1, 2015 (as so amended, the “Rights Agreement”).
RECITALS 
WHEREAS, pursuant to the Rights Agreement, the Company distributed a dividend of one Right for each share of Common Stock outstanding as of the close of business on January 7, 2010 (the “Record Date”);
WHEREAS, the Rights Agreement also authorized the issuance of one Right (as such number may be adjusted as set forth in the Rights Agreement) for each share of Common Stock issued between the Record Date and the earlier of the Distribution Date or the Expiration Date;
WHEREAS, each Right, as adjusted pursuant to the terms of the Rights Agreement, represents the right to purchase ten ten-thousandths of a share of a series of preferred stock of the Company, designated the Series ZZ Junior Participating Cumulative Preferred Stock and having the rights, powers and preferences set forth in a Certificate of Designation filed by the Company with the Secretary of State of the State of Washington (which has since been incorporated into the Company’s Amended and Restated Articles of Incorporation, as amended);
WHEREAS, the Board of Directors of the Company (the “Board of Directors”) has determined that it is in the best interests of the Company and its shareholders to make certain changes to the Rights Agreement (as amended to date). These changes are reflected in this Amendment and include, without limitation, (i) a decrease in the Exercise Price from $80.00 to $16.00; (ii) a decrease in the number of one ten-thousandths of a share of Preferred Stock issuable upon the exercise of a Right from ten ten-thousandths of a share of Preferred Stock to two ten-thousandths of a share of Preferred Stock, and (iii) a decrease in the Redemption Price from $0.001 to $0.0002.
WHEREAS, pursuant to Section 27 of the Rights Agreement, prior to the occurrence of a Section 11(a)(ii) Event, the Company and the Rights Agent shall, if the Board of Directors so directs, supplement or amend any provision of the Rights Agreement as the Board of Directors may deem necessary or desirable without the approval of any holders of certificates representing shares of Common Stock of the Company; and
WHEREAS, all acts necessary to make this Amendment a valid agreement, enforceable in accordance with its terms have been done and performed, and the execution and delivery of this Amendment by the Company has been in all respects duly authorized by the Company.
NOW, THEREFORE, in consideration of the foregoing and the mutual agreements set forth in the Rights Agreement and in this Amendment and for other good and valuable consideration, the parties hereto agree as follows:
1. Amendment to Section 7(b). Sections 7(b) of the Rights Agreement is hereby amended and restated in its entirety to read as follows:
“(b) The Exercise Price for each two ten-thousandths of a share of Preferred Stock pursuant to the exercise of a Right shall initially be Sixteen United States Dollars (U.S. $16.00), shall be subject to adjustment from time to time as provided in Sections 11 and 13 of this Agreement and shall be payable in lawful money of the United States of America in accordance with Section 7(c) below.”

 


2. References to “ten ten-thousandths of a share of Preferred Stock”. For the avoidance of doubt, all references in the Rights Agreement to “ten ten-thousandths of a share of Preferred Stock” shall be “two ten-thousandths of a share of Preferred Stock” as of the date of this Amendment.
3. References to “redemption price of $0.001 per Right”. For the avoidance of doubt, all references in the Rights Agreement to “redemption price of $0.001 per Right” shall be “redemption price of $0.0002 per Right” as of the date of this Amendment.
4. Right Certificate. The form of Right Certificate attached to the Rights Agreement and all other related documents shall be modified, where appropriate, to make reference to this First Amendment and reflect the amendments contained herein.
5. Effectiveness. This Amendment shall be deemed effective as of the date first written above, as if executed on such date. Except as expressly provided herein, the Rights Agreement is not being amended, modified or supplemented in any respect, and it remains in full force and effect.
6. Miscellaneous.
(a) Except as otherwise expressly provided, or unless the context otherwise requires, capitalized terms used in this Amendment shall have the respective meanings assigned to them in the Rights Agreement.
(b) This Amendment shall be deemed to be a contract made under the internal and substantive laws of the State of Washington and for all purposes shall be governed by and construed in accordance with the internal and substantive laws of such State applicable to contracts made and performed entirely within such State, except as otherwise indicated in Section 32 of the Rights Agreement.
(c) If any term, provision, covenant or restriction of this Amendment is held by a court of competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or invalidated; provided, however, that nothing in this Section 6(c) will affect the ability of the Company under the provisions of Section 27 of the Rights Agreement to supplement or amend this Amendment to replace such invalid, void or unenforceable term, provision, covenant or restriction with a legal, valid and enforceable term, provision, covenant or restriction.
(d) Descriptive headings of the several Sections of this Amendment are inserted for convenience only and will not control of affect the meaning or construction of any of the provisions hereof.
(e) This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this Amendment transmitted electronically shall have the same authority, effect, and enforceability as an original signature.
[Signature Pages Follow.]
 
2

 



IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as an instrument under seal and attested, all as of the day and year first above written.
 
ATTEST:
 
CTI BIOPHARMA CORP.
 
 
 
 
By:
 
/s/ Bruce Seeley
 
By:
 
/s/ David Kirske
Name:
 
Bruce Seeley
 
Name:
 
David Kirske
Title:
 
Chief Operating Officer

 
Title:
 
Chief Financial Officer and Executive Vice President
 
 
ATTEST:
 
COMPUTERSHARE TRUST COMPANY, N.A.,
as Rights Agent
 
 
 
 
By:
 
/s/ Lisa Brenton
 
By:
 
/s/ Dennis V. Moccia
Name:
 
Lisa Brenton
 
Name:
 
Dennis V. Moccia
Title:
 
AVP & Senior RM
 
Title:
 
Manager, Contract Administration